# PAVmed Inc. (PAVM) · Edgar & Edgarette company card

> PAVmed (PAVM) saw revenue fall 97.6% in FY2025 to $0 million, operating margin -30713% against a 1.2% median for surgical & medical instruments & apparatus, equity 87.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1624326 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PAVM) · [JSON](https://www.pops4.com/boards/company/PAVM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $71,000 |
| Revenue growth, 1 year | -97.6% |
| Revenue growth per year | -38.6% |
| Operating margin | -30712.7% (prior year -1482.9%) |
| Net margin | -3477.5% |
| Operating cash flow | −$5M |
| Capital spending | $31,000 |
| Free cash flow | −$5M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $39M |
| Total equity | $34M |
| Equity ÷ assets | 87.5% |
| Return on equity | -7.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -25.42 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$5.2M in FY2025); operating loss: a margin of -30712.7% in FY2025; revenue is hard to predict: its 80% range is ±54%

## Edgarette's reading

Exposure: revenue $71K (FY2025). Experience: revenue down 97.6% on the year, down 38.6% a year over 4 years; operating margin -30712.7%, down from -1482.9%. Soundness: equity 87.5% of assets, return on equity -7.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $11K and $38K next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $11K to $41K. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -30712.7% against a 1.2% median; growth -97.6% against 11.6%.

Range logged 2026-09-25, receipt 8fc3c3bf0d44e7df, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-06-24 ([filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226029944/0001493152-26-029944-index.htm))

## Recent filings

- 8-K · filed 2026-10-22 · 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modifications to Rights of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226048138/0001493152-26-048138-index.htm)
- 8-K · filed 2026-09-10 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/0001493152-26-042021-index.htm)
- 8-K · filed 2026-08-14 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226038072/0001493152-26-038072-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000143774926027733/0001437749-26-027733-index.htm)
- 8-K · filed 2026-06-24 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226029944/0001493152-26-029944-index.htm)
- 8-K · filed 2026-05-15 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1624326/000149315226023352/0001493152-26-023352-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001624326.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1624326

## Cite

POPS4, Edgar & Edgarette: PAVmed Inc. (PAVM) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/PAVM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.